Tech Company Financing Transactions
Conatus Pharmaceuticals Funding Round
Private investors participated in a $1 million capital raise for Conatus Pharmaceuticals. This venture round was announced on 6/14/2013.
Transaction Overview
Company Name
Announced On
6/14/2013
Transaction Type
Debt
Amount
$1,001,551
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
16745 West Bernardo Dr. 200
San Diego, CA 92127
USA
San Diego, CA 92127
USA
Phone
Website
Email Address
Overview
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Mento
Chief Operating Officer
Keith Marshall
VP - Finance
Michelle Vandertie
VP - R & D
Alfred Spada
Browse more venture capital transactions:
Prev: 6/14/2013: Silverback Learning Solutions venture capital transaction
Next: 6/14/2013: Wrapp venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs